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Abstract: Chitin-based materials and their derivatives are receiving increased attention in 
tissue  engineering  because  of  their  unique  and  appealing  biological  properties.  In  this 
review,  we  summarize  the  biomedical  potential  of  chitin-based  materials,  specifically 
focusing on chitosan, in tissue engineering approaches for epithelial and soft tissues. Both 
types  of  tissues  play  an  important  role  in  supporting  anatomical  structures  and 
physiological functions. Because of the attractive features of chitin-based materials, many 
characteristics  beneficial  to  tissue  regeneration  including  the  preservation  of  cellular 
phenotype, binding and enhancement of bioactive factors, control of gene expression, and 
synthesis  and  deposition  of  tissue-specific  extracellular  matrix  are  well-regulated  by  
chitin-based  scaffolds.  These  scaffolds  can  be  used  in  repairing  body  surface  linings, 
reconstructing tissue structures, regenerating connective tissue, and supporting nerve and 
vascular  growth  and  connection.  The  novel  use  of  these  scaffolds  in  promoting  the 
regeneration of various tissues originating from the epithelium and soft tissue demonstrates 
that these chitin-based materials have versatile properties and functionality and serve as 
promising substrates for a great number of future applications. 
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1. Introduction 
Chitin is the second most abundant natural polymer and is commonly found in the exoskeletons of 
crustacean and insects as well as the cell walls of fungi. Most chitin applications are based on its 
deacetylated form, chitosan. Chitosan is composed of glucosamine and N-acetyl glucosamine, which 
are linked in a β (1–4) manner (Figure 1). The molecular weight and degree of deacetylation, which 
are critical in determining the characteristics of chitosan, depend on the source and production process 
used [1].  
Chitin-based  materials  have  been  widely  used  in  the  biomedical  field.  These  materials  are 
biocompatible and have been approved for human use [2]. Chitosan can be biodegraded by human 
enzymes, such as lysozyme that breaks the linkage between acetylated units and degrades chitosan to 
oligosaccharides [3]. The degradability of chitin-based material is important for scaffold fabrication, 
because degradation may influence cell behavior and tissue formation of the engineered construct [4]. 
Chitin-based materials also possess a bactericidal effect. The positive charge of the amino group in the 
chitosan polymer can react with anions located on the cell wall of bacteria. This reaction causes the 
bacterial cell to break open and the contents of the bacterial cell leak out. Furthermore, chitosan can 
bind  nucleic  acids  and  interfere  with  protein  synthesis  [4,5].  Because  of  these  unique  features,  
chitin-based materials have broad medical utility.  
An  intriguing  and  important  feature  of  chitin-based  material  is  its  cationic  nature.  In  many 
physiological  situations,  chitosan  can  become  protonated  and  positively-charged  (Figure  1).  The 
positive  charge  of  chitosan  originates from the protonated  amino  groups. The protonation  usually 
occurs  in  acidic  environments  in  vitro  and  in  vivo,  and  increases  the  solubility  of  chitosan  [1,4]. 
Protonated chitosan can form a complex with many types of negatively-charged molecules, such as 
growth factors, nucleic acids, and cytokines [6,7]. This feature allows chitosan to recruit and bind 
bioactive factors from surrounding environments, thereby protecting these factors from degradation 
and increasing local concentration and efficacy [8–12]. This unique property of chitin-based materials 
is significant in the modulation of cell behavior during tissue regeneration. In addition, it is possible 
that positively-charged chitosan interacts with anionic glycosaminoglycans (GAG) and proteoglycans, 
which are essential components in the extracellular matrix (ECM) found throughout the body. Because 
a  variety  of  bioactive  factors  are  regulated  and  are  bound  to  these  ECM  elements,  chitin-based 
materials capable of interacting with GAG or proteoglycans may be competent in modulating these 
substantial factors for tissue formation [13]. 
In the traditional design of biomaterials, bio-inert substrates are favored because of the reduced 
induction of immune responses; these materials are regarded as biocompatible. With advances in the 
understanding of cell-biomaterial interactions, the current design of biomaterial scaffolds has focused 
more on bioactive material systems. Bioactive systems can be established through the development of 
delivery systems for bioactive molecules, or the fabrication of bioactive scaffolds by using physical or 
chemical modifications. To this end, chitin-based material is a candidate of choice. Chitosan has been 
widely applied in drug delivery systems for growth factors, peptides, and bioactive compounds. The 
simple  control  over  the  loading  and  releasing  of  bioactive  agents  renders  chitosan  an  appropriate 
vehicle  for  drug  delivery  [1,14].  When  fabricated  into  tissue-engineered  scaffolds,  chitin-based 
materials  provide  many  functional  chemical  units  that  can  be  readily  modified  for  desired  Int. J. Mol. Sci. 2011, 12                       
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bioactivity [15]. In recent years, chitin-based materials have drawn increasing attention because of 
their potential role in biotechnology and medical applications [1,4]. 
Figure 1. Molecular structures of chitin, chitosan, and protonated chitosan polymer. 
 
Tissue  engineering  employs  aspects  of  molecular  biology,  cell  biology,  material  technology, 
engineering,  and  surgical  intervention  to  develop  tissue  substitutes  to  restore  the  function  and 
architecture of damaged or lost tissues and organs [16–21]. Tissue engineering aims to create new 
tissues and organs by introducing cells, biocompatible materials, and supportive factors. Cell-seeded 
biomaterial matrices can be implanted into the body to initiate functional tissue regeneration. To this 
end,  numerous  biomaterials  ranging  from  natural  to  artificial  polymers  have  been  investigated  to 
construct  scaffolds  for  tissue  engineering  purposes.  Using  chitin-based  materials,  it  is  possible  to 
fabricate different types of scaffolds, such as hydrogels, microcapsules, films, porous structures, and 
fibers. Furthermore, these scaffolds can be modified to yield polymer blends, which are formed with 
desired  structures,  chemical  features,  and  mechanical  properties.  In  addition,  chitosan  is  an 
ecologically-favorable biomaterial with low costs of retrieval and production that can be easily scaled 
up for industrial use [22]. Together, these excellent features render chitin-based materials optimal for 
tissue engineering [23,24].  
Chitin-based  biomaterials  have  favorable  biological  properties  for  tissue  regeneration  [25–27]. 
These materials are well known for their potential when used in tissue regeneration of the skeletal 
system [28–31]. Chitosan possesses properties useful for orthopedic tissue including plastic properties, 
antibacterial  effects,  minimal  foreign  body  reactions,  increased  cell  infiltration,  and  efficacious 
osteoconduction [29]. Therefore, through precisely controlled production, chitin-based biomaterials 
can  harbor  a  predictable  structure  and  ideal  degradation  rates  that  are  suitable  for  bone  graft 
alternatives. Chitin-based materials can also be incorporated with bioactive factors that are beneficial 
to osteogenesis [29]. In light of these characteristics, chitin-based materials have been widely used as Int. J. Mol. Sci. 2011, 12                       
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scaffold substrates for orthopedic tissue engineering in clinical applications [29]. 
Tissues derived from epithelium and soft tissues are generally responsible for covering, supporting, 
and connecting organs within the body. These tissues play major roles in maintaining body contours 
and providing mechanical cushion and protection [32]. Generally, these tissues are constructed with 
ECM that has water as its main component. Although chitin-based materials can be readily constructed 
into networks that allow the free diffusion of water and bioactive molecules, these materials have not 
been comprehensively examined for their roles in the engineering of epithelial-derived organs and soft 
tissues. For decades, chitin-based materials have been known for their effects in promoting wound 
healing [33–36]. This application exemplifies a typical use of chitin-based materials in recovering 
epithelium and soft tissue. Recently, an increasing number of studies have demonstrated the potential 
of chitin-based materials in tissue engineering of epithelial and soft tissues. These studies extend the 
scope from simple epithelial reunion to the regeneration of many types of related tissues. This review 
will focus on the latest developments in the applications of chitin-based materials in tissue engineering 
by presenting some representative progress in the tissue regeneration of epithelial-derived organs and 
soft tissues. 
2. Scaffolds in Tissue Engineering 
2.1. Chitin-based Scaffolds 
Tissue  engineering  combines  the  use  of  cells,  bioactive  factors,  and  supporting  structures  to 
regenerate  and  substitute  damaged  tissue  structures  and  repair  functionality. For  tissue specificity, 
using  appropriate  materials  for  scaffold  construction  is  imperative.  An  ideal  material  used  for 
fabricating tissue-engineered scaffolds is expected to provide both structural support and control of 
bioactivity.  In  this  regard,  chitin-based  materials  are  regarded  as  appropriate  candidates  because  
of  their  biodegradable  properties  and  ability  to  be  easily  fabricated  into  distinct  types  of  tissue  
scaffolds  [11,37].  In  addition,  it  is  likely  that  chitosan  can  enhance  cell  function  and  regulate 
biomolecules  [37,38].  Physical  entrapment,  chemical  immobilization,  or  the  grafting  of  bioactive 
factors in engineered chitin-based biomaterials can generate biologically active scaffolds.  
Chitin-based materials can be readily fabricated into many forms of scaffolds, including hydrogels, 
microcapsules,  membranous  films,  sponges,  tubes,  and  a  variety  of  three-dimensional  porous  
structure [15,39]. Chitosan hydrogel can be prepared and crosslinked either covalently or ionically. 
Covalent crosslinking provides chitosan hydrogel with a permanent architecture that can be used to 
absorb and release bioactive factors or water. In contrast, ionically crosslinked chitosan hydrogel is 
formed by using reversible linkages. Because ionically crosslinked chitosan hydrogel can be dissolved, 
it  is  generally  regarded  as  a  tissue-tolerated  scaffold.  Moreover,  chitin-based  scaffolds  can  be 
generated  in  the  form  of  an  interconnected  porous  architecture  [40].  Using  the  internal  bubbling 
process, the size, distribution, and morphology of the pores within chitosan scaffolds can be easily 
controlled.  The  three-dimensional  porous  chitosan  structure  can  be  applied  to  a  variety  of  tissue 
scaffolds. This structure resembles the tissue structure of several solid organs, and can be used to 
create regenerative scaffolds [41]. When chitin-based materials are fabricated into tubular forms, they 
can be successfully applied in the tissue engineering of nerves and blood vessels [42–44]. Chitin-based 
scaffolds are therefore versatile and can be optimized for various regenerative purposes [45]. Int. J. Mol. Sci. 2011, 12                       
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In epithelial and soft tissue engineering, generating scaffolds with porous structures is important. 
Instead of mechanically strong properties, the reproduction of a flexible and plastic nature is required 
for regenerating epithelial and soft tissues. Chitosan can be fabricated into a porous structure that 
allows  cells  to  be  seeded.  The  space  created  by  the  porous  structure  facilitates  cell  proliferation, 
migration,  and  nutrient  exchange.  In  addition,  the  controllable  porosity  of  chitosan  scaffolds  is 
beneficial to angiogenesis, which is important in supporting the survival and function of regenerated 
soft tissue [11,46]. Furthermore, various types of glycoproteins and proteoglycans exist in the ECM of 
soft  tissue,  and  most  have  anionic  properties  that  can  easily  interact  with  chitosan  [47].  These 
molecules  are  capable  of  binding  to  and  regulating  many  bioactive  factors;  thus,  this  activity 
contributes strongly to the advantageousness of chitosan when used as a scaffold substrate in tissue 
engineering. Because chitosan resembles GAG in structure, it has been suggested that chitosan might 
mimic GAG in regulating and modulating many bioactive factors [48]. These characteristics are also 
helpful in retaining bioactivity within a tissue scaffold during in vitro cell seeding or in vivo implantation.  
Based on these properties, chitosan scaffolds have been widely used in epithelial and soft tissue 
engineering  [33,35,38,49,50].  The  chitosan  scaffolds  show  both  cytocompatibility  in  vitro  and 
biocompatibility in vivo [25]. Generally, chitosan evokes only a minimal foreign body reaction in vivo, 
and  implanted  chitosan  scaffolds  seldom  induce  chitosan-specific  reactions  [37].  Although  many 
migratory  neutrophils  appear  initially,  few  inflammatory  reactions  to  chitosan  occur.  In  addition, 
tissue-specific matrix deposition and active angiogenic activity are observed within implanted chitosan 
scaffolds [37]. These results provide evidence  of the utility of chitosan in fabricating implantable 
scaffolds for tissue regeneration. 
2.2. Blended Chitin-based Scaffolds 
Despite positive characteristics, chitin-based materials have some disadvantages regarding tissue 
regenerative purposes. Cell seeding is a critical step in constructing bioengineered tissues. For some 
cells of specific tissue types, chitin-based biomaterials do not provide a friendly interface for cell 
adhesion [51–53]. Therefore, other biomaterials, such as collagen or fibronectin with tissue-specific 
binding  sequence,  should  be  blended  with  chitosan  to  produce  scaffolds  with  higher  cell  
affinity [52,53]. In addition to cell attachment, chitosan also restrains the migration and movement of 
certain types of cells. In tissue development, cell migration plays a major role in establishing tissue 
structure. Therefore, other materials that are more appropriate for directing the desired cell behaviors 
should be used [54,55]. The maintenance of cell survival and phenotypes, and the direction of cell 
differentiation  are  also  critical  to  biomaterial  selection.  Chitosan  has  been  shown  to  promote cell 
survival  and  neurite  outgrowth  when  incorporated  with  poly-D-lysine  [56].  Moreover,  because 
chitosan  usually  lacks  sufficient  mechanical  strength,  it  is  either  replaced  by  other  substrates  or 
blended  with  other  polymers  when  used  in  tissue  engineering  of  the  skeletal  system.  Although 
mechanical  strength  is  not  of  major  concern  in  the  engineering  of  epithelial  and  soft  tissues,  the 
requirement of appropriate tissue stiffness, as needed in connective tissue, still limits the utility of pure 
chitosan scaffolds. Because different tissues and cells vary in morphology, function, and structure, 
scaffold selection and fabrication should be well-selected and customized. 
Many  tissue-specific  requirements  benefit  from  blended  chitosan  scaffolds.  Blends  of  different 
polymers can exhibit a wide range of chemical, physical, and biological properties in generating a Int. J. Mol. Sci. 2011, 12                       
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substrate  for  tissue-specific  regeneration.  Chitosan  has  shown its  utility  as  a  polymer that  can be 
blended  with  other  materials  to  generate  tissue-favorable  scaffolds.  These  blended  scaffolds show 
favorable mechanical, chemical, and biological properties while preserving the unique characteristics 
of chitosan. In ligament regeneration, chitosan-hyaluronan hybrid polymers can provide appropriate 
environments  for  cellular  adhesion,  proliferation,  and  ECM  production,  as  well  as  facilitate  the 
biological effects of seeded cells [57]. To mimic the morphological and mechanical properties of blood 
vessels and improve long-term patency rates, collagen has been crosslinked with chitosan to generate a 
tubular  scaffold.  This  biocompatible  scaffold  demonstrated  desirable  porosity  and  pliability,  and 
enhanced  cell  adhesion,  proliferation,  and  ECM  production  [58,59].  In  addition  to  vascular 
applications,  chitosan/collagen  blended  scaffolds  have  also  been  employed  in  adipose  tissue 
regeneration. When adipocytes were seeded, the in vitro cytocompatibility and in vivo biocompatibility 
of scaffolds were confirmed experimentally. Vascularization induction and adipose tissue formation 
were also observed [60]. When a blended chitosan scaffold was prepared with gelatin, the scaffold 
possessed the proper swelling property and burst strength, and it showed an appropriate environment 
for the growth and spread of vascular smooth muscle cells [44]. When mixed with silk fibroin, blended 
chitosan scaffolds exhibit increased ultimate tensile strength, elastic modulus, and water capacity [61]. 
This  scaffold  has  been  successfully  applied  in  musculofascial  tissue  engineering  to  repair  an 
abdominal wall defect [62]. Together, these representative blended chitin-based scaffolds demonstrate 
greater porosity, greater water uptake, and improved cellular adhesion for tissue-specific requirements 
(Table 1). 
Table  1.  Different  chitin-based  scaffolds  blended  with  natural  polymers  used  in  tissue 
engineering of epithelial organ and soft tissue. 
Scaffold  Application  Effect  Ref. 
Chitosan-hyaluronan  Ligament   Cellular adhesion  
Cell proliferation 
ECM and production 
[57] 
Chitosan/Collagen  Blood vessel  Cell adhesion 
Cell proliferation 
ECM production 
[58,59] 
Chitosan/Collagen  Adipose tissue  Vascularization induction  
Adipose tissue formation 
[60] 
Chitosan/Collagen  Skin  Cell proliferation 
Cell infiltration 
[63] 
Collagen-chitosan/fibrin glue  Skin  Cell growth  [64] 
Collagen-glycosaminoglycan-chitosan  Oral mucosa  Cell differentiation 
Cell proliferation 
ECM production 
[65] 
Chitosan/gelatin  Skin  Cell survival  [66] 
Chitosan/gelatin  Blood vessel  Cell growth 
Cell migration 
[44] 
Chitosan/silk fibroin  Musculofascia  ECM deposition 
Vascularization 
Cellular infiltration 
[62] Int. J. Mol. Sci. 2011, 12                       
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2.3. Chitosan Scaffolds Loaded with Bioactive Molecules 
To  increase  the  efficacy  and  completeness  of  tissue  regeneration,  several  tissue  engineering 
strategies have been employed, including changing the structure or the porosity of the scaffold [67,68], 
modifying the scaffold by introducing ECM elements [69,70], seeding the scaffold with cells [70,71], 
and applying bioactive molecules [72,73]. Among these strategies, the use of a scaffold containing 
bioactive molecules such as growth factors may be useful for facilitating tissue regeneration. Using 
this method, molecules that play an important role in guiding and modulating tissue regeneration can 
be delivered in a controlled manner to the exact site where cell differentiation and proliferation are 
expected to occur [74]. To this end, the in vivo efficacy of growth factors is critical, and the technology 
of  drug  delivery,  particularly  those  designed  in  controlled-release  formulations,  is  more  suitable. 
Therefore,  many  controlled-release  systems  have  been  applied  in  fabricating  tissue-engineered 
constructs to deliver essential growth factors and nutrients. 
Structurally,  chitosan  is  an  unbranched,  long-chained  polymer  that  is  composed  of  repeated 
disaccharide moieties. Therefore, it is generally considered to resemble the structure of  GAG and 
believed to mimic its function in the modulation of cell behaviors and phenotypes [48]. Based on the 
cationic nature of the chitosan polymer, an ionic complex can be formed between chitosan and specific 
bioactive  compounds.  This  interaction  leads  to  the  spontaneous  formation  of  polyelectrolyte 
complexes  by  establishing  strong,  but  reversible  links.  The  temporary  polyelectrolyte  complex 
networks  formed  without  covalent  cross-linkers  are  more  biocompatible,  sensitive,  and  easily 
controlled. These features render chitosan a competent material for loading and releasing bioactive 
factors in a precisely controlled manner [1,23,75], and chitosan can be widely applied to the delivery 
of proteins, peptides, drugs, and extracellular components.  
In addition to being positively charged, chitosan pocesses structurally intriguing properties that 
allow the introduction of desired biological function. Chitosan has abundantly reactive hydroxyl and 
amino units and can be functionally modified to increase biomaterial diversity. The biological activity 
beneficial to tissue regeneration can be introduced through the entrapment of bioactive agents in the 
scaffolds  through  physical  adsorption  [15].  Moreover,  molecules  of  interest,  such  as  peptides  or 
proteins, can be incorporated into the chitosan scaffold by the formation of imide bonds [76,77]. The 
amine groups in the chitosan structure can be used to prepare different reactive chitosan derivatives. 
For example, trimethylated chitosan has been reported to be efficient in gene transfection without 
increasing cytotoxicity [78]. A chitosan tube immobilized with laminin peptides can facilitate proximal 
nerve sprouting and regenerate axon bridging [79]. These modifications render chitin-based materials 
more  diverse  and  functional  as  well as  facilitate  the development of bioactive and  tissue-friendly 
scaffolds for tissue regeneration. 
Chitin-based  materials  have  been  described  in  the  fabrication  of  tissue-engineered  constructs 
conjugated with bioactive factors. For example, a chitin-based scaffold has been loaded with fibroblast 
growth factor 2 (FGF2) for periodontal tissue regeneration. The scaffold promoted structure formation, 
cell proliferation, and the mineralization of regenerated tissue [73]. Similar effects have been shown in 
accelerating  wound  healing  [80].  A  mixture  of  chitin-based  hydrogel  infused  with  a  recombinant 
human epidermal growth factor (EGF) was effective in increasing local EGF concentration, enhancing 
keratinocyte differentiation, and facilitating the wound healing process [81]. Similar effects have been Int. J. Mol. Sci. 2011, 12                       
 
 
1943 
demonstrated  in  chitin-based  scaffolds  incorporating  FGF2  [8]  or  platelet-derived  growth  factor  
(PDGF) [82]. Likewise, vascularization has been promoted using chitin-based scaffolds mixed with 
FGF2  [83].  Furthermore,  the  biological  effects  of  DNA  plasmids  have  been  delivered  using  
chitin-based scaffolds. When a vascular endothelial growth factor (VEGF) plasmid was incorporated 
into a chitin-based scaffold, a greater density of newly-formed and mature vessels was generated in a 
porcine  model  of  skin  defects  [84].  In  a  nerve  regeneration  study,  interferon-gamma  (IFN-γ)  was 
immobilized onto a chitin-based scaffold to induce differentiation of neural progenitor cells [72]. The 
same results were observed in periodontal tissue regeneration by incorporating transforming growth 
factor-beta 1 (TGF-β1) into a chitosan scaffold [85]. All cases show the versatility of chitin-based 
materials in cooperating with numerous factors to increase bioactive function during the regeneration 
of epithelial-derived organs and soft tissues (Table 2). 
Table 2. Chitin-based scaffold loaded with bioactive molecules in tissue engineering of 
epithelial and soft tissue. 
Scaffold  Factor  Application  Effect  Ref. 
Chitosan- 
hydroxyapatite 
FGF2  Periodontal tissue   Cellular structure formation 
Cell proliferation  
Mineralization 
[73] 
Chitosan hydrogel  FGF2  Wound healing  Wound healing, Angiogenesis  [8] 
Chitosan hydrogel  FGF2  Vascularization  Angiogenesis  [83] 
Chitosan  FGF2  Wound healing  Fibroblast proliferation, 
Vasculogenesis 
[80] 
Chitosan- 
Pluronic 
EGF  Wound healing  Keratinocyte differentiation 
Wound healing 
[81] 
Chitosan- 
collagen gel 
PDGF  Wound healing  Wound healing 
Biomimetic effects 
Chemotactic effects 
[82] 
collagen-
chitosan/silicone  
VEFG  Vascularization  Angiogenesis 
Vasculogenesis 
[84] 
Methacrylamide 
chitosan scaffold 
IFN-γ   Nerve regeneration  Differentiation of neural 
progenitor cells 
[72] 
Chitosan/Collagen   TGF-β1  Periodontal Tissue  Tissue regeneration  [85] 
3. Biological Modulation in Tissue Engineering 
3.1. Cell Preservation 
Regulating cell phenotypes in a controlled manner is critical to the success of tissue regeneration-related 
biotechnology. When functional cells are isolated, the applied methodology is expected to preserve the 
inherent original phenotypes to maintain cell function. If pluripotent cells are used, their stemness and 
multi-functionality should be maintained during the processing procedure. However, when these cells 
are applied to the target organ, the desired differentiated status is expected to be induced and fulfill 
tissue functions. Therefore, the role of biomaterials in regulating and maintaining cell phenotype is the 
main issue of current research in tissue engineering.  Int. J. Mol. Sci. 2011, 12                       
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Chitin-based  materials  have  demonstrated  their  potential  in  maintaining  and  inducing  cell 
phenotypes.  When  chitosan  was  used  in  culturing  melanocytes,  the  unique  phenotypic  features  
of  melanocytes  were  retained  [86].  Similar  results  were  also  observed  in  culturing  corneal 
keratinocytes [87] and skin keratinocytes [81]. For anterior cruciate ligament (ACL) cells, cell function 
could  be  induced  with  chitosan  [88].  Likewise,  differentiation  of  mucociliary  epithelial  cells 
originating  from  the  respiratory  tract  was  promoted  by  chitosan  [53].  In  addition,  chitin-based 
materials were also capable of maintaining the stemness and inducing the differentiation of many 
progenitor cells. Chitosan scaffolds have been employed in neural stem cells (NSCs). When different 
forms of chitosan scaffolds were used, distinct differentiated phenotypes of NSCs could be controlled. 
NSCs  cultured  on  films  differentiated  into  astrocytes,  whereas  NSCs  cultured  on  microconduits 
increased  neuronal  differentiation.  In  a  chitosan  porous  structure,  NSCs  differentiated  toward  
neurons [89]. When a chitin-based scaffold was used for cultivating adipose tissue-derived stem cells 
(ADSCs),  stem  cell  characteristics  and  pluripotency  were  preserved  [90].  Pluripotency  was  also 
preserved in embryonic stem-(ES) like cells in vitro [91]. When stem cells were co-cultured with 
endothelial  cells  on  chitin-based  scaffolds,  these  cells  demonstrated  characteristics  affecting  cell 
adhesion and migration [92]. Based on these studies, chitosan shows great promise in the development 
of tissue-specific scaffolds for regulating cell phenotype. 
3.2. Regulation of Gene Expression 
In  tissue  engineering  approaches,  biomaterials  that  not  only  support  cell  attachment  and 
proliferation but also induce cell-inherent function are appealing. Most cell functions are controlled by 
gene expression, which mediates the production of essential factors for desired biochemical functions. 
Although gene modulation using the methods of molecular biology prevails, biosafety remains an issue 
when these methods are employed in clinical applications. The use of biomaterial provides another 
option. By introducing appropriate materials, cell response and gene expression can be regulated. For 
tissue regeneration, this technique may be more convenient and efficient.  
The capacity of chitin-based materials for regulating gene expression has been documented in bone 
and cartilage tissue engineering [93]. In addition, growth factors were released from activated human 
platelets after chitosan stimulation [94]. Effects relevant to epithelial tissue engineering were initially 
demonstrated  by  the  effect  of  chitosan  on  wound  healing.  After  the  application  of  chitosan, 
macrophages were stimulated to produce TGF-β1 and PDGF. In addition, specific ECM components, 
including fibronectin and type I and III collagens, were produced in cultured fibroblasts [95]. Similar 
functions were exhibited in soft tissue engineering by upregulating TGF-β1 in seeded anterior cruciate 
ligament cells [96].  
3.3. Bioactive Molecule Regulation 
Chitosan  can  react  with  several  molecules  and  substrates  via  electrostatic  and  hydrophobic 
interaction.  In  this  way,  the  functions  of  various  bioactive  molecules  have  been  significantly 
modulated by chitosan. For tissue genesis, a repertoire of factors acts on cells in a temporally and 
spatially controlled manner. Therefore, providing tropic and tissue-specific molecules is critical for the 
success of tissue regeneration. Exogenous supplementation of bioactive factors usually has a short Int. J. Mol. Sci. 2011, 12                       
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reaction time and loses bioactivity quickly; thus, it has been difficult to achieve the expected effects 
consistently.  By  using  chitin-based  materials  as  supporting  scaffolds,  these  disadvantages  can  be 
surmounted  and  minimized.  In  addition  to  harnessing  the  endogenous  activity  of  these  factors, 
functional enhancement also can be mediated by chitosan in some applications.  
In  the  salivary  gland,  the  morphogenetic  efficacy  of  mesenchyme-derived  growth  factors  is 
dramatically augmented with the assistance of chitosan. The effects of epithelial morphogenetic factors, 
such  as  fibroblast  growth  factors  7  (FGF7),  fibroblast  growth  factor  10  (FGF10),  and  hepatocyte 
growth  factor  (HGF),  have  been  upregulated  in  the presence  of chitosan. These  factors promoted 
specific epithelial morphogenesis  and proliferative and chemotactic activities [12] (Figure 2). The 
synergy between FGF7 and chitosan, which recruited mesothelial cells more extensively, has been 
applied to reduce pericardial adhesions [97]. When FGF-2 was prepared with chitosan, the retained 
FGF-2  remained  biologically  active  with  a  prolonged  half-life.  Chitosan  can  protect  FGF-2  from 
inactivation and thus prolonged FGF-2 activity [10]. EGF administered with chitosan can maintain 
keratinocyte  differentiation  with  increased  local  concentration  [81].  Therefore,  by  intensifying  the 
bioactive  factors  in  tissue  genesis  and  promoting  functional  recovery,  chitin-based  materials  can 
regulate key factors, expanding its role from a structural-supporting scaffold (Table 3). 
Figure 2. Salivary explants cultured with chitosan demonstrated remarkable lobular formation 
(A) and development of duct-like structures (B) (Scale bar: 100 µ m). (Adapted from [12]). 
 
Table 3. Activity modulation of bioactive molecules by chitin-based scaffolds in tissue 
engineering applications. 
Molecule  Tissue/Organ  Effect  Ref. 
FGF7  Salivary gland  Lobular formation 
Cell proliferation 
[12] 
FGF7  Mesothelium  Synergistic effect 
Adhesion decrease 
[97] 
FGF10  Salivary gland  Ductal elongation 
Cell proliferation 
[12] 
HGF  Salivary gland  Cell migration 
Cell proliferation 
Chemotaxis 
[12] 
FGF2  Vasculature  Cell proliferation  [10] 
FGF2  Periodontal tissue  Cell proliferation  [73] 
EGF  Skin  Cell differentiation  [81] Int. J. Mol. Sci. 2011, 12                       
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3.4. Extracellular Matrix Production and Deposition 
The production and deposition of tissue-specific ECM is required for cell survival, organization, 
and  tissue  genesis.  Therefore,  biomaterials  used  for  tissue  regeneration  are  expected  to  modulate  
ECM-producing cells. Moreover, tissue regeneration can be mediated through supporting materials 
that facilitates the production and deposition of ECM proteins in a tissue-specific manner [98]. Thus, 
materials capable of promoting ECM production are required for tissue regeneration. 
Chitosan  can  stimulate  cultivated  cells  to  produce  ECM  (Table  4).  In  wound  healing  studies,  
chitin-based materials induced collagen fiber formation [99,100]. Type I, III and IV collagens were 
largely synthesized in implants made of chitin-based materials [101]. Although some studies have 
indicated that chitosan does not directly accelerate ECM production by cells, the increased synthesis of 
ECM-related growth factors might promote ECM production [95]. In the formation of intricate tissue 
structures, the presence of specific types of ECM is a requisite for organizing tissue architecture. The 
salivary  gland  is  an  epithelial-derived  organ  characterized  by  ramified  structures;  the  concisely 
controlled appearance of specific components of the ECM is critical for morphogenesis [102]. With the 
assistance of a chitosan scaffold, the process could be accelerated in vitro [98]. Chitosan is a bioactive 
material used by the cell to synthesize and deposit essential ECM, which facilitates ensuing branch 
formation [98] (Figure 3). In joint connective tissue, cells cultured on a chitosan scaffold dramatically 
increased  collagen  production,  further  confirming  that  ECM  production  by  cultured  cells  can  be 
regulated by chitosan scaffolds [54,57,103]. Isolated human mesenchymal stem cells cultured on a 
chitosan scaffold showed an increased rate of collagen production [104], similar to the results of an  
in vivo study [37,62]. 
Table 4. Production and deposition of ECM components by chitin-based scaffolds in tissue 
engineering of epithelial and soft tissue. 
ECM component  Tissue/Organ  Effect  Ref. 
Collagen, Type I  Skin  Wound healing  [101] 
  Salivary gland  Branching morphogenesis  [98] 
  Ligament  Cell proliferation  [57] 
  Vessel  Cell phenotype  [58] 
  tendon  Cell ECM production  [103] 
Collagen, Type III  Skin  Wound healing  [101] 
  Salivary gland  Branching morphogenesis  [98] 
  Ligament  Cell phenotypes  [54] 
Collagen, Type IV  Skin  Wound healing  [101] 
Glycosaminoglycan  Vessel  Cell phenotype  [58] 
 Int. J. Mol. Sci. 2011, 12                       
 
 
1947 
Figure 3. Extracellular matrix distribution and synthesis in salivary gland explants cultured 
with chitosan. (A) Distribution of type I collagen (green) in the epithelial-mesenchymal 
interface (arrowheads) of cultured salivary explants with and without chitosan (DAPI: blue; 
Col I: type  I  collagen;  Scale  bar:  20 µ m); (B) The relative expression level of type I 
collagen was demonstrated using quantitative PCR. 
 
Other ECM components required for tissue regeneration are affected by chitin-based scaffolds. For 
instance,  in  cultured  human  venous  fibroblasts,  a  chitin-based  engineered  construct  demonstrated 
increased  GAG  content  after  culture  [58].  GAG  is  an  important  component  of  soft  tissue.  These 
components can interact with protein to form proteoglycans, which can retain water molecules and 
increase water content. GAG also serves as a reservoir of essential bioactive factors [12]. Accordingly, 
by playing a role in regulating the synthesis of major ECM elements, chitin-based materials assist 
seeded  cells  in  regenerating  tissue.  By  creating  a  biomaterial  closely  resembling  the  native  ECM 
environment, chitin-based materials show attractive features for epithelial and soft tissue engineering. 
4. Applications 
4.1. Chitin-based Materials in the Tissue Engineering of Surface-lining Layers 
The body surface needs to be covered by specific tissue layers to establish a protective barrier 
against environmental threats. The outermost layer of the animal body consists of epithelial-derived 
tissue.  The  main  function  of  an  epithelial  organ  is  to  provide  protection  and  facilitate  secretion. 
Clinically,  defects  created  by  skin  loss,  such  as  large  burns  or  chronic  wounds,  have  remained 
challenging until recently. 
Injured skin needs to be immediately covered with a dressing to restore tissue integrity, maintain 
homeostasis,  and  prevent the  invasion  of microorganisms.  An optimal dressing should  establish  a 
barrier  to  environmental  irritants,  maintain  a  moist  environment,  and  allow  gaseous  exchange. 
Therefore, biomaterials that possess the properties of biocompatibility, non-allergenicity, promotion of 
wound healing, and antimicrobial activities are regarded as ideal candidates. Chitin-based materials 
have been widely used as materials in the repair of skin tissue defect. Many features of chitin-based 
materials confer advantages over other materials for skin regeneration, including the promotion of cell 
infiltration, ECM production, antimicrobial properties, and maintenance of homeostasis [33,35,50,105]. 
In  addition,  chitin-based  biomaterials  demonstrate  superior  capacity  in  tissue  adhesion  and  gas Int. J. Mol. Sci. 2011, 12                       
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permeability, which helps to accelerate wound healing. Moreover, quaternary ammonium groups that 
are present within chitin-based materials efficiently interact with the cell. Thus, chitin-based materials 
possess  high  competence  against  microorganisms  [106].  Chitosan  can  also  be  helpful  during  the 
different phases  of wound repair  [99]. The competence  of chitosan  in  maintaining  homeostasis is 
beneficial  during  the  inflammatory  stage,  and  its  ability  to  stimulate  fibroblast  proliferation  and 
inflammatory cell migration are also helpful for re-epithelization. Therefore, chitin-based materials 
and their derivatives have been made in a variety of forms for wound dressing [105]. Because of their 
antibacterial capability, chitin-based materials are fabricated into bandages [107]. These bandages are 
now regularly utilized from the bedsides to the battlefield, and are available both commercially and 
industrially [108]. Currently, similar products are being tested in clinical trials of wound debridement, 
chronic  ulcers,  and  dental  dressings.  Therefore,  because  of  their  favorable  biological  and 
physicochemical characteristics, chitin-based materials are considered useful substrates for promoting 
the recovery of defective surface linings. 
In the early developmental stages of skin tissue engineering, collagen-based scaffolds, which are 
composed  of  essential  compounds  of  connective  tissue,  were  initially  used  [109].  However,  these 
scaffolds  were  obtained  via  chemical  crosslinking  for  the  acquisition  of  mechanical  and  material 
properties.  With  chitosan,  a  similar  scaffold  can  be  fabricated  without  using  any  chemical  
reagent [110]. In terms of functional characterization, the blended scaffold is comprehensively helpful 
for  dermal  reconstruction.  Newly-formed  ECM  can  be  generated  using  macromolecules,  such  as 
collagen, fibronectin, and elastin, and an organized architecture can be established. Furthermore, a 
differentiated  epidermis  with  multilayers  is  formed  by  expressing  essential  molecules  in  the  
dermo-epidermal junction [110]. This scaffold is regarded as a successful skin equivalent and shows 
great potential in cosmetic dermatology and for pharmaceutical uses [110]. 
Drug-carrying  capacity  of  chitin-based  scaffolds  has  also  been  applied  to  the  fabrication  of 
engineered skin scaffolds. These chitin-based scaffolds are fabricated and heparinized for angiogenic 
factor delivery. The heparinized scaffold has shown an enhancement of  angiogenesis after in vivo 
implantation  [59].  When  FGF2  was  added,  the  wound  healing  rate  increased  [80].  The  results 
demonstrate that loading chitin-based scaffolds with angiogenic factors has potential use in developing 
a vascularized artificial dermis. Based on these experiences, the future development of engineered skin 
scaffolds will require the release of several essential molecules in a well-controlled manner, allowing 
engineered tissue equivalents to mimic native skin and increase their clinical utility [63,109,111]. 
To  engineer  an  artificial  product  that  can  substitute  for  real  skin,  it  is  necessary  to  regenerate 
appendages and their associated skin features. The ideal engineered skin tissue should be pigmented to 
protect against irradiation. One skin disease amenable to treatment with tissue engineering is vitiligo, a 
common disfiguring and depigmenting disorder that destroys melanocytes. Extensive vitiligo lesions 
require  melanocyte  transplantation.  Improved  melanocyte  transplantation  is  achieved  by  culturing 
melanocytes  on  appropriate  biomaterials  to  form  a  cellular  patch.  Chitosan-containing  scaffolds 
support  the  growth  and  phenotypic  maintenance  of  melanocytes.  It  has  been  demonstrated  that 
melanocyte spheroids, which retain melanocyte viability, were formed on a chitosan-coated surface. 
When cells were reinoculated onto other surfaces, the cells regained their dendritic phenotypes. These 
results show that a three-dimensional culture system constructed of chitosan may serve as a cellular 
patch for vitiligo treatment [86]. Int. J. Mol. Sci. 2011, 12                       
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In addition to skin regeneration, organs located on the body surface, such as the eyes, also require 
regenerating coverage when a defect occurs. Corneal defects are major clinical issues in ocular surface 
reconstruction. For cornea regeneration, scaffolding methods can promote corneal epithelial healing 
and preserve native cell phenotypes. Clinically, an amniotic membrane is routinely used as a scaffold 
to promote corneal epithelial wound healing and preserve the original phenotypes of corneal epithelial 
cells [112]. When chitosan is prepared in a membranous form to culture corneal epithelial cells, it 
shows a similar capacity in supporting the growth of cultured corneal epithelial cells. With chitosan, 
cells  can  grow  without  any  change  of  their  endogenous  characteristics.  Chitosan  also  assists  in 
preserving the phenotypes of the keratinocytes, which are the primary cells on the ocular surface that 
regulate  stromal  ECM  and  improve  wound  healing.  Cultured  on  a  chitosan  surface,  corneal 
keratinocytes formed in spheroid shapes that were beneficial in preserving the original features for 
subsequent  transplantation  [87].  The  spheroids  were  generated  by  cell  aggregation  instead  of  cell 
proliferation  and  had  a  higher  capacity  for  regeneration.  These  results  suggest  that  the  use  of  
chitin-based biomaterials is another choice for treating ocular surface disorder [113]. 
Similarly, in the aerodigestive system, chitin-related biomaterials are useful for tissue engineering. 
By coculturing human oral epithelial cells and fibroblasts in a porous collagen–glycosaminoglycan–
chitosan  scaffold,  an  oral  mucosa  equivalent  was  engineered  [65].  The  engineered  mucosa  tissue 
resembles human native oral mucosa manifested by nonkeratinized full-thickness tissue structure. The 
tissue-engineered human oral mucosa can be used to close mucosal wound resulting from disease or 
medical therapy. Most surfaces in the respiratory tract are covered by ciliated respiratory epithelium. 
Without  this  epithelial  lining,  occurrences  of  inflammation,  bleeding,  and  nasal  crusting  might  
ensue  [114].  A  tissue-engineered  scaffold  could  provide  physical  support  and  regulate  respiratory 
epithelial  cell  growth,  adhesion,  and  differentiation.  Collagen  was  initially  used  in  constructing 
aerodigestive  epithelia  because  of  tissue  similarity  [115].  The  unsuitable  degradation  rate  and 
mechanical strength of collagen have made its application infeasible [116]. When collagen is blended 
with  chitosan  to  prepare  a  scaffold,  it  improves  biocompatibility  and  promotes  mucociliary 
differentiation  in  nasoepithelial  cells  [53].  Chitosan  also  increases  the  mechanical  strength  of  
collagen-based  scaffolds  and  facilitates  cultured  cells  in  expressing  tissue-specific  epithelial  
markers  [117].  Accordingly,  chitin-based  materials  are  appropriate  grafting  materials  for  airway 
epithelia and can be used as scaffolds in engineering airway linings for respiratory system regeneration. 
4.2. Chitin-based Materials in Tissue Structure Formation 
In  addition  to  outer  surface  linings,  many  tissues  have  unique  cellular  architectures  that  are 
organized in well-designed tissue patterns. With these unique structures, tissue-specific physiological 
functions  can  be  efficiently  fulfilled.  For  instance,  many  tissues  are  characterized  by  a branching 
structure,  which  helps  to  create  the  larger  cellular  surfaces  that  are  necessary  for  metabolic 
requirements. In embryonic development, ramified structures are generally generated by branching 
morphogenesis [118,119]. The salivary gland, an organ responsible for saliva secretion and regulation, 
is typically formed by this process. To engineer this unique tissue structure, an appropriate scaffold 
that  helps  to  recapitulate  the  branching  processes  must  be  found.  For  this  purpose,  chitin-based 
scaffolds  can  provide  preferential  characteristics  for  enhancing  salivary  gland  branching  [98].  By 
interacting with cultured salivary tissue, chitosan can induce salivary cells to synthesize and deposit  Int. J. Mol. Sci. 2011, 12                       
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collagen-related  ECM,  which  is  beneficial  to  branch  formation.  Other  biocompatible  and 
biodegradable  biomaterials,  such  as  lactic-co-glycolic  acid  and  poly  epsilon-caprolactone,  do  not 
support  branch  formation  and  decrease  cell  migration  and  viability  [120].  Thus,  chitin-based 
biomaterials are superior substrates for enhancing the branching morphogenesis of the salivary gland. 
In  addition  to  facilitating  ECM  production  for  branching  morphogenesis,  chitosan  promotes 
epithelial-mesenchymal  interactions  during  organogenesis.  During  tissue  formation,  a  reciprocal 
interaction between the epithelium and mesenchyme is required [121]. Using chitosan, the efficacy of 
mesenchymal  morphogenetic  instruction  toward  salivary  epithelium  is  promoted,  generating  that 
particular tissue structure more efficiently [12]. In the repertoire of tissue formation, the tissue-specific 
morphogenetic  effect  of  mesenchyme-derived  factors,  such  as  FGF7,  FGF10,  and  HGF,  are  all 
reinforced. In addition, the proliferative and chemotactic properties of these morphogens are enhanced. 
These results demonstrate the promising potential of chitin-based biomaterials in regenerating tissue 
structure. By comprehensively intensifying the essential mesenchyme-derived growth factors, chitosan 
can facilitate the formation of salivary epithelial architecture. These results demonstrate the novel 
functions  of  chitosan,  serving  as  a  scaffold  for  tissue  structural  formation  and  as  a  regulator  of 
morphogenetic factors. Both functions are essential in organogenesis [12]. 
Chitosan’s ability to promote tissue structure formation is specific, unique, and largely affected by 
molecular  weight  and  specific  chemical  linkages  [122].  Furthermore,  chitosan  can  independently 
induce salivary branching under serum-free conditions [12]. In previous reports, serum was required 
for  tissue  interactions  between  the  salivary  epithelium  and  mesenchyme  [123,124].  The 
supplementation of serum is beneficial to salivary morphogenesis because it provides many essential 
factors [125]. However, for tissue regeneration, the addition of  serum might be costly and impair 
biocompatibility. These results suggest a novel role of chitosan in reducing the need for serum in tissue 
engineering, an important step towards future clinical use. 
4.3. Chitin-based Material in Connective Tissue Engineering 
Within the body, connective tissue plays a role in maintaining contour and shape, surrounding or 
separating  organs,  relaying  contractile  forces,  and  modulating  physiological  functions.  There  is 
evidence that chitin-based materials are implicated in the regenerative applications of connective tissue. 
In  the  joints  of  the  extremities,  ligaments  are  important  tissues  to  maintain  body  stability  and 
movement. From a tissue engineering perspective,  the use of a scaffold is necessary for ligament 
regeneration to help related cells reestablish a similar tissue environment [88,96,126]. When human 
ACL fibroblasts were cultured with chitosan, a specific gene profile that regulates matrix production 
was  up-regulated.  This  advantage  compensated  for  insufficient  matrix  production  by  native  
well-differentiated ACL cells. Without supplemental chemical reagents, chitosan-based biomaterials 
can  specifically  control  cellular  morphologies,  regulate  gene  expression,  and  increase  protein  
production [96].  
Similar effects are observed when chitin-based scaffolds are used to promote periodontal tissue 
regeneration. In blended chitosan scaffolds loaded with FGF2, both periodontal ligament cells and 
cementoblasts have demonstrated vigorous proliferation and migration [73]. A blended chitin-based 
scaffold has been used to repair a musculofascial defect. The abdominal wall defect was remodeled, 
showing seamless integration with adjacent native tissue and mechanical strength similar to native Int. J. Mol. Sci. 2011, 12                       
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tissue [62]. Together, these results indicate that chitin-based materials could provide a cell-favorable 
environment for connective tissue regeneration. 
4.4. Chitin-based Material in Nerve Tissue Engineering 
To  repair  peripheral  nerve  injuries  with  neural  gaps,  the  current  standard  treatment  uses  an 
autologous nerve graft to bridge the neural gap and facilitate nerve regeneration and reconnection. 
Engineered nerve grafts are usually composed of a neural scaffold, seeded supportive cells, and growth 
factors  [127]. Among  the various  biomaterials under investigation, scaffolds made of chitin-based 
materials have drawn much attention [128]. Chitin-based materials support neuronal growth [129]. In 
addition, many different substrates and bioactive molecules have been added into chitin-based scaffold 
to increase their affinity with nerve cells [130–133]. For examples, polyglycolic acid fibers added to a 
chitosan nerve scaffold were used to reconnect a long sciatic nerve gap in a dog model and a long 
median nerve gap in a clinical study [134,135]. Furthermore, when the scaffold was seeded with bone 
marrow mesenchymal cells, a longer neural gap of up to 50 mm in length was repaired in a dog sciatic 
nerve [136]. Therefore, a chitin-based, nerve-guiding scaffold can successfully connect long gaps and 
promote nerve regeneration and functional recovery. 
In nerve regeneration, Schwann cell (SC) supports neurite outgrowth by releasing neurotrophic 
factors, expressing neuron-specific ligands, guiding neurite outgrowth, and producing and depositing 
ECM [137]. A chitosan scaffold can support SC adhesion, migration, and proliferation [138], and 
induce SC alignment, leading to oriented axonal growth and preventing neuroma formation [139]. In 
addition, chitosan scaffolds have sufficient mechanical strength to maintain the conduit space, provide 
a  favorable  environment  for  cell  migration  and  attachment,  and  improve  the  permeation  of  
neurite-related factors [43]. Because of the SC alignment along the scaffolds, oriented fibrous sheets 
were established. After transplantation in vivo, vigorous sprouting myelinated axons were found and 
nerve  function  was  recovered.  These  results  demonstrate  that  engineered  nerve  conduits  made  of  
chitin-based materials comprehensively support neurite regeneration. 
 4.5. Chitin-based Material in Adipose Tissue Engineering 
Adipose tissue defects resulting from congenital abnormalities, trauma, senile alteration, or medical 
treatments significantly affect patients’ health, appearance, and quality of life. The current therapeutic 
modalities  that  include  primary  closure,  flap  transplantation,  or  material  implantation  are  not  
ideal  given  clinical  requirements.  The  main  goal  of  adipose  tissue  engineering  is  to  design  a  
scaffold  that  mimics  native  adipose  tissue  and  maintains  a  three-dimensional  volume  following 
implantation [140,141]. For this purpose, chitin-based materials have been used for adipose tissue 
engineering. Prepared in a blended form, the scaffold could provide appropriate micro-architecture and 
water holding capacity. When seeded with cells, biocompatibility has been confirmed both in vitro and 
in  vivo.  After  transplantation  into  animals,  the  scaffolds  induced  vascularization  and  successfully 
generated  adipose  tissue  [142].  Accordingly,  these  reports  demonstrate  the  feasibility  of  applying 
chitin-based scaffolds to adipose tissue engineering. Int. J. Mol. Sci. 2011, 12                       
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4.6. Chitin-based Material in Vascular Tissue Engineering 
In many engineered tissue equivalents, an established vascular system is critical to the ensuing 
survival and functionality of the engineered organs. For survival of transplanted tissue, angiogenesis 
and neovascularization must occur. In addition, transplantation with vessel grafting is needed to treat 
vascular  diseases.  Therefore,  materials  that  serve  as  vascular  grafting  substitutes  or  induce 
angiogenesis have been of interest for decades [143]. 
Chitin-based scaffolds have been widely investigated for use in constructing vascular substitutes. 
Chitosan promotes endothelial cell migration in wound healing [144]. Blended collagen and chitosan 
scaffolds hold further promise as scaffolds for vascular tissue engineering [58,145]. In vitro studies 
confirm the capacity of these scaffolds in supporting cell attachment, growth, and proliferation. These 
scaffolds have mechanical properties similar to native blood vessels and superior biocompatibility 
after transplantation. Moreover, chitin-based materials can facilitate ingrowth of connective tissues 
which promotes neo-vascularization after implantation [145]. When GAG is incorporated into chitosan, 
its effects on inhibiting vascular smooth muscle cell growth and coagulation counteract the difficulties 
of incomplete endothelialization and muscle hyperplasia [146]. Moreover, heparin–chitosan scaffolds 
can be applied in vascular tissue engineering because heparin is effective in reducing thrombosis and 
recruiting related growth factors [83,147,148]. In vivo results have demonstrated that the heparin–chitosan 
scaffolds can stimulate cell proliferation to form a thick vascularized granulation [146]. These studies 
demonstrate the feasibility of applying composite chitin-based scaffolds in vascular tissue engineering. 
In addition to acting as scaffold components, chitin-based materials can deliver bioactive molecules 
for vessel regeneration [83,149]. When chitosan is prepared as a hydrogel, the incorporated angiogenic 
factors,  such  as  FGF2,  can  be  gradually  released  in  vivo  with  hydrogel  degradation.  Retained  in 
chitosan hydrogel, the activity of biomolecules remains stable. When tested in vivo, hydrogel injection 
results  in  a  significant  increase  in  newly-formed  blood  vessels  and  fibrous  tissue  formation.  The 
controlled release of angiogenic factors from chitosan hydrogel effectively reconstructed collateral 
circulation  and  recovered  ischemic  limbs  in  animal  models  [150].  In  addition,  a  gene-activated 
engineered tissue was developed using chitin-based materials. When VEGF DNA was incorporated 
into a blended chitosan scaffold, many newly-formed and mature vessels formed [84]. Thus, it has 
been  proposed  that  chitin-based  materials  are  potential  delivery  vehicles  for  bioactive  factors  in 
vascular tissue engineering. 
5. Current State, Challenge, and Future Prospects 
This review summarizes the utility of chitin-based materials in engineering tissues that originate 
from epithelium and soft tissue. Successful applications in several biomedical fields demonstrate that 
chitin-based materials have made a significant contribution to relevant tissue regeneration. Because of 
the favorable biological properties, including the preservation of cellular phenotypes, enhancement of 
bioactive molecules  efficacy, gene  regulation, and  tissue-specific ECM production and deposition, 
chitin and chitosan-related materials are attractive scaffolds in regenerating epithelial-derived organs 
and soft tissues. 
Recent research shows that chitin-based material can be used as a bioactive tissue engineering 
scaffold and acts as an efficient carrier of bioactive molecules. The results demonstrate the tremendous Int. J. Mol. Sci. 2011, 12                       
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potential  of  chitin-based  material  for  clinical  applications.  Nonetheless,  until  recently,  most 
applications  had  been  investigated  only  in  the  laboratory.  Only  a  few  products  of  chitin-based 
materials, such as dressings designed for wound care, have been successfully transferred from bench to 
bedside. The currently ongoing clinical trials of chitin and chitosan-related material products mostly 
focus  on  topical  hemostatic  control  and  metabolic  regulation.  For  these  clinical  applications,  
chitin-based materials are fabricated into sponges or microcapsules to increase the surface for tissue 
interactions and enhance the efficiency of bioactive factor delivery. Chitin-based materials produced in 
spongy forms lack mechanical strength and precise control of their bioactive factor release. Materials 
designed for encapsulation only provide the capacity to load and release biomolecules  and do not 
provide structural support for tissue regeneration [15]. It is likely that a variety of properties unique to 
chitin-based materials have seldom been applied in fabricating clinically applicable scaffold. Therefore, 
current progress in clinical studies is not as advanced as academic research. 
In  the  engineering  of  epithelial  and  soft  tissues,  the  accurate  control  of  bioactive  molecules, 
particularly  those  related  to  tissue  development  and  morphogenesis,  is  imperative.  During 
organogenesis, these key factors always appear in a precise spatial and temporal manner to direct 
tissue formation.  Because  of  stringent  regulation of  the natural developmental blueprint, the ideal 
scaffold should be designed to release  bioactive factors sufficiently and effectively. In addition, a 
variety of growth factors and morphogens are involved in tissue formation. Therefore, next generation 
scaffolds should be able to carry many different bioactive factors, and release them in specific order. 
To this end, decisions on how to control the separate loading capacity, kinetics of drug release, and  
rate of substrate degradation are the major challenges to be faced. Because of the unique features  
of  chitin-based  material  that  have  been  mentioned  above,  a  chitin-related  substrate  might  be  the 
substrate  with  the  greatest  potential.  Furthermore,  because  epithelial  and  soft  tissues  have  an  
important  stereo-architecture,  the  ability  to  transfer  current  knowledge  regarding  two-dimensional  
cell-biomaterial interactions into three-dimensions is required in developing a bulk scaffold for in vivo 
animal and clinical studies. In achieving these aims, the biologically attractive features of chitin-based 
materials can be fully utilized, and these may facilitate the transition of the technology from bench  
to bedside. 
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